41.11 USD
↗ 0.15 (0.36%)AT CLOSE (11:59 AM EDT)
Franklin Genomic Advancements ETF
HELXBATS • USD
41.14
↗ 0.03 (0.07%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
41.14
↗ 0.03 (0.07%)
Market: CLOSED
Shares of Franklin Genomic Advancements ETF (HELX) are trading at $41.11. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Jul 6, 2026.
Open?$40.98
High?$41.17
Low?$40.89
Prev. Close?$40.96
Volume?2.4K
Avg. Volume?N/A
VWAP?$41.04
Bid / Ask
Bid?$0.00 × 0
Ask?$44.85 × 100
Spread?$44.85
Midpoint?$22.43
Valuation & Ratios
Market Cap?N/A
Shares Out?700.0K
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
No description available.
Employees
N/A
Market Cap
N/A
Industry
N/A
Website
N/A
Listed
2020-02-25
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?71
Momentum?98
Short Sent.?28
Piotroski F-Score?6/9Mixed
Altman Z-Score?2.98Safe
Confidence?50%Low
Short InterestVery High
Short Interest?7.7K
Days to Cover?13.8
Avg Daily Volume557
Settlement Date2026-06-15